🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
STUDY BACKGROUND AND PURPOSE: Acute myelogenous leukemia (AML) is a common...
Status
Terminated
Location
Winship Cancer Institute of Emory University
Start Date
2013-11
Trial ID
NCT02234037
Treatments Being Tested
The researchers are doing this study to find out whether a 3-drug combinati...
Status
Recruiting
Location
Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2026-01-27
Trial ID
NCT07392242
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Status
Not Yet Recruiting
Location
Daping Hospital, Third Military Medical University (Army Medical University)
Start Date
2025-02-01
Trial ID
NCT06778902
Treatments Being Tested
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Johns Hopkins Oncology Center
Start Date
1998-04
Trial ID
NCT00003361
Treatments Being Tested
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
The main aim of the study is to see if signs and symptoms of myelodysplasti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04985656
Treatments Being Tested
This phase I/II trial investigates the side effects and best dose of veneto...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-09-04
Trial ID
NCT04550442
Treatments Being Tested
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
Status
Active Not Recruiting
Location
City of Hope /ID# 154105
Start Date
2017-02-02
Trial ID
NCT02993523
Treatments Being Tested
The primary objective of study Part A is to assess the safety of talacotuzu...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-04
Trial ID
NCT02472145
Treatments Being Tested